# SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy

> **NCT03606642** · PHASE2 · TERMINATED · sponsor: **HonorHealth Research Institute** · enrollment: 50 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis
- Stent Placement

## Interventions

- **DRUG:** Dual Antiplatelet (DAPT) Therapy
- **DEVICE:** The Synergy® stent

## Key facts

- **NCT ID:** NCT03606642
- **Lead sponsor:** HonorHealth Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-19
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-08-08
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** The DSMC March 16, 2022 reviewed of Interim Analysis and recommendation due to no glaring outcomes found to date.
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606642, "SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03606642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*